PCSK1 and Alzheimer disease: In this study, we propose that Nec‐1 regulates multiple pathological culprits that are important in AD and suggest drug repositioning to regulate all aspects of AD in a comprehensive manner, from underlying neuropathological changes to outward symptomatic outcomes.